12. November 2022
S.T.A.R.S. – Resident Evil Network by RPD42
17. November 2022

CCON | COMIC CON STUTTGART 2022 | Game-Tipp | Marvel's Midnight Suns

CCON – Game Tip:


Marvel’s Midnight Suns is a new tactical role-playing game set on the darker side of the Marvel universe that sends you into battle against demonic forces of the underworld. But you won’t be alone in this, you’ll even live together with your allies – Earth’s last line of defense, the Midnight Suns.


  • YOUR MARVEL ADVENTURE. You are the Hunter, the first officially customizable original hero:in in the Marvel Universe. Lead a legendary squad of heroes from the ranks of the Avengers, the X-Men, the Runaways and other superhero groups. Build your own team and customize your skill selection to match your play style. Unlock cult outfits that will make the heart of any Marvel fan beat faster.
  • EXPLORE THE DARKER SIDE OF MARVEL. Rise up against Lilith’s demonic forces and experience an immersive personal story that takes familiar hero:ins into an unknown world of the supernatural and mystical. Never before has so much been at stake. To stop Lilith from resurrecting her evil master Chthon, you’ll also have to battle fallen versions of legendary Marvel characters.
  • LIVE AMONG THE LEGENDS. Get to know the heros from a whole new angle and unlock additional abilities as you build relationships away from the battlefield with your favorite hero:s from the Marvel universe and strengthen your personal bond with legends like Iron Man, Wolverine and Captain Marvel. Explore the “Abbey,” your mystical secret base, to discover its hidden secrets.
  • FIGHT AND THINK LIKE A SUPERHERO. The creators of the critically acclaimed XCOM series present a new gripping and highly customizable combat system with superhero flair that rewards clever ideas. Team up with other superhero:in, analyze the battlefield, and overwhelm the forces of darkness with devastating cult attacks.

    Sources & additional links for Marvel’s Midnight Suns:

    Website with more information


    Comments are closed.